^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

19(T2)28z1xx TRAC T cell

i
Other names: 19(T2)28z1xx TRAC T cell, 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells
Associations
Company:
Memorial Sloan-Kettering Cancer Center, Takeda
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
7d
Study of 19(T2)28z1xx TRAC-Chimeric Antigen Receptor (CAR) T Cells in People with B-Cell Lymphoma (clinicaltrials.gov)
P1, N=30, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Recruiting --> Active, not recruiting
Enrollment closed
|
CD20 (Membrane Spanning 4-Domains A1)
|
19(T2)28z1xx TRAC T cell
over1year
New P1 trial
|
CD20 (Membrane Spanning 4-Domains A1)
|
19(T2)28z1xx TRAC T cell